Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 11Recruiting 6Active not recruiting 5Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1Classical hematology 1

Conditions

Obesity 20Mucositis 19Constipation 13Neoplasms 11Opioid-Induced Constipation 9Pain 8Overweight 6Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Sexual Dysfunction, Physiological 4Bronchiolitis Obliterans Syndrome 4Xerostomia 3Stomatitis 3Radiation Injuries 3Polycystic Ovary Syndrome 3Endometrial Neoplasms 3Breast Neoplasms 3Sedentary Behavior 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Multiple Myeloma 2Glucose Intolerance 2Dyspnea 2Chemotherapy-induced Peripheral Neuropathy 2Venous Thromboembolism 1Urinary Incontinence 1Thyroid Diseases 1Stomach Ulcer 1Stomach Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Diabetes Mellitus, Type 2 × Other × Clear all
NCT05315908 2024-02-28

COVID-19 Testing in Underserved and Vulnerable Populations

University of California, San Diego

Phase NA Terminated
9,120 enrolled 8 charts
Classical hematologyOther

Anemia, Sickle Cell, Coronary Artery Disease, Diabetes Mellitus, Type 2, Heart Failure, Neoplasms, Obesity, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡